Formelregister


L01F A
CD20 (differensieringsklynge 20)-hemmere
L01F A01
Rituksimab
L01F A03
Obinutuzumab
L01F B
CD22 (differensieringsklynge 22)-hemmere
L01F B01
Inotuzumabozogamicin
L01F C
CD38 (differensieringsklynge 38)-hemmere
L01F C01
Daratumumab
L01F C02
Isatuksimab
L01F D
HER2 (human epidermal vekstfaktorreseptor 2)-hemmere
L01F D01
Trastuzumab
L01F D02
Pertuzumab
L01F D03
Trastuzumabemtansin
L01F D04
Trastuzumabderukstekan
L01F E
EGFR (epidermal vekstfaktorreseptor)-hemmere
L01F E01
Cetuksimab
L01F E02
Panitumumab
L01F F
PD-1​/​PDL-1 (programmert celledødprotein-1​/​programmert dødsligand-1)-hemmere
L01F F01
Nivolumab
L01F F02
Pembrolizumab
L01F F03
Durvalumab
L01F F04
Avelumab
L01F F05
Atezolizumab
L01F F06
Cemiplimab
L01F F07
Dostarlimab
L01F F09
Tislelizumab
L01F F13
Toripalimab
L01F G
VEGF​/​VEGFR (vaskulær endotelial vekstfaktor)-hemmere
L01F G01
Bevacizumab
L01F G02
Ramucirumab
L01F X
Andre monoklonale antistoffer og antistoff-legemiddelkonjugater
L01F X02
Gemtuzumabozogamicin
L01F X04
Ipilimumab
L01F X05
Brentuksimabvedotin
L01F X06
Dinutuksimab beta
L01F X07
Blinatumomab
L01F X08
Elotuzumab
L01F X09
Mogamulizumab
L01F X12
Tafasitamab
L01F X13
Enfortumabvedotin
L01F X14
Polatuzumabvedotin
L01F X15
Belantamabmafodotin
L01F X17
Sacituzumabgovitekan
L01F X18
Amivantamab
L01F X20
Tremelimumab
L01F X24
Teklistamab
L01F X26
Mirvetuksimabsoravtansin
L01F X27
Epkoritamab
L01F X28
Glofitamab
L01F X29
Talkvetamab
L01F X31
Zolbetuksimab
L01F X32
Elranatamab
L01F Y
Kombinasjoner av monoklonale antistoffer og antistoff-legemiddelkonjugater
L01F Y01
Pertuzumab og trastuzumab
L01F Y02
Nivolumab og relatlimab


Utskrift (pdf)